Your browser doesn't support javascript.
loading
Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release Tofacitinib.
Lamba, M; Hutmacher, M M; Furst, D E; Dikranian, A; Dowty, M E; Conrado, D; Stock, T; Nduaka, C; Cook, J; Krishnaswami, S.
Affiliation
  • Lamba M; Pfizer Inc, Groton, Connecticut, USA.
  • Hutmacher MM; Ann Arbor Pharmacometrics Group, Ann Arbor, Michigan, USA.
  • Furst DE; University of California, Los Angeles, California, USA.
  • Dikranian A; San Diego Arthritis Medical Clinic, San Diego, California, USA.
  • Dowty ME; Pfizer Inc, Cambridge, Massachusetts, USA.
  • Conrado D; Pfizer Inc, Groton, Connecticut, USA.
  • Stock T; Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Nduaka C; Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Cook J; Pfizer Inc, Groton, Connecticut, USA.
  • Krishnaswami S; Pfizer Inc, Groton, Connecticut, USA.
Clin Pharmacol Ther ; 101(6): 745-753, 2017 Jun.
Article in En | MEDLINE | ID: mdl-27859030
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrimidines / Pyrroles / Protein Kinase Inhibitors / Janus Kinases / Models, Biological / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Country/Region as subject: America do norte Language: En Journal: Clin Pharmacol Ther Year: 2017 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrimidines / Pyrroles / Protein Kinase Inhibitors / Janus Kinases / Models, Biological / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Country/Region as subject: America do norte Language: En Journal: Clin Pharmacol Ther Year: 2017 Document type: Article Affiliation country: